CCG
IBB icon

Cypress Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Cypress Capital Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,498
Closed -$434K – 241
2018
Q4 		$434K Sell
4,498
-616
-12% -$65.4K 0.1% 151
2018
Q3 		$623K Buy
5,114
+300
+6% +$35.3K 0.12% 150
2018
Q2 		$529K Buy
4,814
+600
+14% +$64.2K 0.11% 152
2018
Q1 		$449K Buy
+4,214
New +$467K 0.09% 159
2016
Q4 		– Sell
-2,580
Closed -$249K – 187
2016
Q3 		$249K Buy
+2,580
New +$245K 0.06% 162
2015
Q3 		– Sell
-1,920
Closed -$236K – 197
2015
Q2 		$236K Buy
+1,920
New +$230K 0.05% 188

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return